Citadel Advisors
DMTK

Citadel Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Citadel Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-207,375
Closed -$146K – 15753
2024
Q1 		$146K Sell
207,375
-109,418
-35% -$124K ﹤0.01% 10809
2023
Q4 		$554K Buy
316,793
+304,802
+2,542% +$445K ﹤0.01% 7878
2023
Q3 		$17.3K Buy
11,991
+9,927
+481% +$24.8K ﹤0.01% 12737
2023
Q2 		$5.37K Buy
+2,064
New +$6.17K ﹤0.01% 13510
2023
Q1 		– Sell
-56,441
Closed -$238K – 15749
2022
Q4 		$99.9K Buy
56,441
+26,755
+90% +$71.2K ﹤0.01% 11218
2022
Q3 		$118K Sell
29,686
-118,471
-80% -$729K ﹤0.01% 10955
2022
Q2 		$821K Buy
148,157
+43,705
+42% +$358K ﹤0.01% 7484
2022
Q1 		$1.53M Buy
104,452
+37,967
+57% +$508K ﹤0.01% 6680
2021
Q4 		$1.05M Buy
66,485
+20,157
+44% +$484K ﹤0.01% 7834
2021
Q3 		$1.49M Sell
46,328
-54,874
-54% -$1.93M ﹤0.01% 7099
2021
Q2 		$4.21M Buy
101,202
+21,360
+27% +$877K ﹤0.01% 4814
2021
Q1 		$4.05M Buy
79,842
+69,312
+658% +$3.63M ﹤0.01% 4729
2020
Q4 		$342K Buy
+10,530
New +$149K ﹤0.01% 8845

Other funds holding DMTK

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Citadel Advisors's DMTK Position: Q2 2024 in Review

Citadel Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 207,375 shares — an estimated $146K sold.

Citadel Advisors first reported a position in DMTK in Q4 2020 and held it in 13 quarters. The position peaked at $4.21M in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Citadel Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 207,375 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $146K.
  • Citadel Advisors first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
  • Citadel Advisors's DermTech, Inc. Common Stock position peaked at $4.21M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.